Vildagliptin/Metformin Hydrochloride

维格列汀/盐酸二甲双胍

Report date: 2026/03/30 17:02:26

Base Information

Drug NameVildagliptin/Metformin Hydrochloride
Drug Alias Name维格列汀•盐酸二甲双胍Metformin/Vildagliptin维格列汀和盐酸二甲双胍Metformin Hydrochloride/Vildagliptin维格列汀/二甲双胍 +[17] 
ClassificationSmall molecules
Mechanisms of ActionDipeptidyl peptidase IV inhibitorsProtein kinase AMP-activated non-catalytic subunit beta 1 activators
TargetsDipeptidyl peptidase IVProtein kinase AMP-activated non-catalytic subunit beta 1
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsDiabetes Mellitus, Type 2
Approved Indications in ChinaDiabetes Mellitus, Type 2
Original Approved Country/TerritoryEU
Original Approved Date2007/11/14
Country/TerritoryUnited StatesGermanySouth Korea +[6] 
CombinationsYes Metformin HydrochlorideVildagliptin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesDr. Reddy's Laboratories LLCBio-innova Co LtdNovartis Pharma Schweiz Ag +[6] 
Inactive CompaniesHanmi Pharmaceutical Co Ltd
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD08
Related LinksKEGG